YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer

G Kuser-Abali, A Alptekin, M Lewis, IP Garraway… - Nature …, 2015 - nature.com
The transcriptional co-activator Yes-associated protein 1 (YAP1), a key nuclear effector of
the Hippo pathway, is a potent oncogene, and yet, the interaction between YAP1 and …

YAP antagonizes TEAD‐mediated AR signaling and prostate cancer growth

X Li, S Zhuo, YS Cho, Y Liu, Y Yang, J Zhu… - The EMBO journal, 2023 - embopress.org
Hippo signaling restricts tumor growth by inhibiting the oncogenic potential of YAP/TAZ‐
TEAD transcriptional complex. Here, we uncover a context‐dependent tumor suppressor …

The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells

L Zhang, S Yang, X Chen, S Stauffer, F Yu… - … and cellular biology, 2015 - Taylor & Francis
Yes-associated protein (YAP) is an effector of the Hippo tumor suppressor pathway. The
functional significance of YAP in prostate cancer has remained elusive. In this study, we first …

The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

S Cheng, N Prieto-Dominguez, S Yang… - Prostate cancer and …, 2020 - nature.com
Background After long-term androgen deprivation therapy, 25–30% prostate cancer (PCa)
acquires an aggressive neuroendocrine (NE) phenotype. Dysregulation of YAP1, a key …

The hippo pathway in prostate cancer

O Salem, CG Hansen - Cells, 2019 - mdpi.com
Despite recent efforts, prostate cancer (PCa) remains one of the most common cancers in
men. Currently, there is no effective treatment for castration-resistant prostate cancer …

[HTML][HTML] Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension

FK Collak, U Demir, S Ozkanli, E Kurum… - Cancer biology & …, 2017 - ncbi.nlm.nih.gov
Objective: Yes associated protein 1 (YAP1) is a member of the Hippo pathway, acting as a
transcriptional coactivator. To elucidate the role of YAP1 and phosphorylated (p) YAP1 in …

ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer

CY Liu, T Yu, Y Huang, L Cui, W Hong - Journal of Biological Chemistry, 2017 - ASBMB
Prostate cancer is a very common malignant disease and a leading cause of death for men
in the Western world. Tumorigenesis and progression of prostate cancer involves multiple …

NEK1 phosphorylation of YAP promotes its stabilization and transcriptional output

MI Khalil, I Ghosh, V Singh, J Chen, H Zhu… - Cancers, 2020 - mdpi.com
Simple Summary We earlier described the involvement of the TLK1> NEK1> ATR> Chk1
axis as a key determinant of cell cycle arrest in androgen-dependent prostate cancer (PCa) …

P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis

M Zhu, R Peng, X Liang, Z Lan, M Tang, P Hou… - Oncogene, 2021 - nature.com
Abstract Yes-associated protein 1 (YAP1), a key player in the Hippo pathway, has been
shown to play a critical role in tumor progression. However, the role of YAP1 in prostate …

RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer

SE Lee, JU Lee, MH Lee, MJ Ryu, SJ Kim, YK Kim… - Oncogenesis, 2013 - nature.com
The transcription coactivator Yes-associated protein 1 (YAP1) is regulated by the Hippo
tumor suppressor pathway. However, the role of YAP1 in thyroid cancer, which is frequently …